Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com
A16492 | Pages: 270 | Charts: 63 | Tables: 174 |
The global cosmetic surgery market size was valued at $67.3 billion in 2021, and is projected to reach $201.0 billion by 2031, growing at a CAGR of 11.6% from 2022 to 2031. Cosmetic surgery is voluntary procedure which is perform to reshape their body, body contouring and improve the physical appearance of patients. Cosmetic procedure involves unique discipline of surgical and non-surgical techniques which aims to improve person’s appearance. Cosmetic surgical procedure includes different type of surgeries like breast augmentation, rhinoplasty (Nose reshaping), liposuction, facelift, eyelid surgery (blepharoplasty). Along with that there are some gender specific cosmetic surgeries, in female genital cosmetic surgery includes numerous procedures, including hymenoplasty, labia majora augmentation, vaginoplasty, labiaplasty and G-spot amplification and in male breast reduction (gynecomastia surgery). Cosmetic surgeries can perform when body reach the full adult size. Generally, in male, at the age of 15-16 cosmetic surgeries can perform and in female, at the age of 14-15 cosmetic surgeries can perform.
The growth of the global cosmetic surgery market share is majorly driven by increase in prevalence of cosmetic surgical procedure; rise in demand for aesthetic procedure; and rise in technological advancement in healthcare sector. According to American Society of Plastic Surgeon, in 2020, it was reported that around 352,555 rhinoplasty procedure are performed in U.S in 2020. It was analyzed that the rhinoplasty was the leading surgical procedure performed in the U.S in 2020.
Get more information on this report : Request Sample Pages
Furthermore, increase in number of approval for cosmetic surgical products drives cosmetic surgery market growth. For instance, in January 2021, Johnson and Johnson, a medical device and pharmaceutical company, received approval from U.S. Food and Drug Administration (FDA) for new mentor memorygel boost breast implant for breast augmentation in women. In addition, increase in demand for aesthetic procedure is anticipated to contribute toward cosmetic surgery market growth. Moreover, the increase in number of young female population, an rise in awareness about the skin treatment, surge the demand for cosmetic surgical procedure, and propel the cosmetic surgery market size. According to American Society of Plastic Surgeon, in 2020, it was reported that around 2 million cosmetic surgical procedure are conducted in female population
Furthermore, technological development in the medical device industry to manufacture advanced cosmetic surgical products is expected to provide remunerative opportunities for expansion of the global cosmetic surgery market during the cosmetic surgery market forecast. Moreover, presence of key manufacturing companies to manufacture cosmetic surgery products and rise in expenditure on healthcare products propel growth of the market. Initiatives taken by government and private organizations to develop healthcare industry propel the growth of the market. However, the side effect associated with cosmetic surgery, and high cost of cosmetic surgical procedure is expected to restrict the market growth during the forecast period.
The cosmetic surgery market is segmented into procedure, gender, age group, provider, and region. By procedure, the market is categorized into breast augmentation, eyelid surgery, liposuction, rhinoplasty, and others.
On the basis of gender, it is divided into female, and male. Depending on age group, it is categorized into 13 to 29, 30 to 54, and 54 and above.Depending on provider, it is categorized into Ambulatory surgical facilities, Hospital & clinics, and office and cosmetic surgical center.
[GENDERGRAPH]
Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, Columbia, and rest of LAMEA).
By type, the female segment was the major contributor in 2021, and is expected to maintain its lead during the forecast period, owing to increase in demand for aesthetic procedures, and rapidly growing emphasis on personal aesthetics among females, and increase in number of female populations conducting cosmetic surgery.
[AGEGROUPGRAPH]
On the basis of age group, the 30-54 segment dominated the market in 2021, and this trend is expected to continue during the forecast period, owing increase in demand for liposuction, and rise in number of cosmetic procedures in population of age group 30 to 54.
[PROCEDUREGRAPH]
Depending on procedure, the breast augmentation segment dominated the market in 2021, and this trend is expected to continue during the forecast period, owing increase in number of breast augmentation procedures, and increase in number of approvals for cosmetic surgeries in breast implant.
[ENDUSERGRAPH]
On the basis of Provider, the hospital a clinic segment dominated the market in 2021, and this trend is expected to continue during the forecast period, owing increase in number of cosmetic surgeries, and rise in number of hospitals and clinics to conduct various surgical procedures.
North America garnered a major share in the demand for cosmetic surgery market in 2021, and is expected to continue to dominate during the forecast period, owing rise in number of breast augmentation procedures, increase in number of approvals for cosmetic surgery products, presence of cosmetic surgery industry, and advancements in healthcare, medical devices, and aesthetic sector in the region. Asia-Pacific is anticipated to witness lucrative growth, owing to increase in number of liposuctions, rise in awareness among young population regarding aesthetics sector, growth in health care expenditures, and rise in adoption of aesthetic products.
The key players operating in the global cosmetic surgery market include AbbVie Inc., Bausch Health Companies Inc., Candela Syneron, Cynosure Technologies, Galderma SA, Johnson and Johnson, Merz Pharma GmbH & Co. KGaA, Sientra Inc, Sinclair Pharma, Teoxane Laboratories.
Key Market Segments
Key Market Players